1	Bio-Technology	_	NNP	_	_	2	NAME	_	_
2	General	_	NNP	_	_	4	SBJ	_	_
3	Corp.	_	NNP	_	_	2	POSTHON	_	_
4	received	_	VBD	_	_	0	ROOT	_	_
5	tenders	_	NNS	_	_	4	OBJ	_	_
6	for	_	IN	_	_	5	NMOD	_	_
7	97.9	_	CD	_	_	8	NMOD	_	_
8	%	_	NN	_	_	6	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	its	_	PRP$	_	_	16	NMOD	_	_
11	7.5	_	CD	_	_	12	AMOD	_	_
12	%	_	NN	_	_	16	NMOD	_	_
13	convertible	_	JJ	_	_	16	NMOD	_	_
14	senior	_	JJ	_	_	16	NMOD	_	_
15	subordinated	_	VBN	_	_	16	NMOD	_	_
16	notes	_	NNS	_	_	9	PMOD	_	_
17	due	_	JJ	_	_	16	APPO	_	_
18	April	_	NNP	_	_	17	TMP	_	_
19	15	_	CD	_	_	18	NMOD	_	_
20	,	_	,	_	_	18	P	_	_
21	1997	_	CD	_	_	18	APPO	_	_
22	,	_	,	_	_	8	P	_	_
23	and	_	CC	_	_	8	COORD	_	_
24	96	_	CD	_	_	25	NMOD	_	_
25	%	_	NN	_	_	23	CONJ	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	its	_	PRP$	_	_	33	NMOD	_	_
28	11	_	CD	_	_	29	AMOD	_	_
29	%	_	NN	_	_	33	NMOD	_	_
30	convertible	_	JJ	_	_	33	NMOD	_	_
31	senior	_	JJ	_	_	33	NMOD	_	_
32	subordinated	_	VBN	_	_	33	NMOD	_	_
33	debentures	_	NNS	_	_	26	PMOD	_	_
34	due	_	JJ	_	_	33	APPO	_	_
35	March	_	NNP	_	_	34	TMP	_	_
36	1	_	CD	_	_	35	NMOD	_	_
37	,	_	,	_	_	35	P	_	_
38	2006	_	CD	_	_	35	APPO	_	_
39	.	_	.	_	_	4	P	_	_

1	In	_	IN	_	_	15	LOC	_	_
2	exchange	_	NN	_	_	3	NMOD	_	_
3	offers	_	NNS	_	_	1	PMOD	_	_
4	that	_	WDT	_	_	5	SBJ	_	_
5	expired	_	VBD	_	_	3	NMOD	_	_
6	Friday	_	NNP	_	_	5	TMP	_	_
7	,	_	,	_	_	15	P	_	_
8	holders	_	NNS	_	_	15	SBJ	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	each	_	DT	_	_	11	NMOD	_	_
11	$	_	$	_	_	9	PMOD	_	_
12	1,000	_	CD	_	_	11	NMOD	_	_
13	of	_	IN	_	_	11	NMOD	_	_
14	notes	_	NNS	_	_	13	PMOD	_	_
15	will	_	MD	_	_	0	ROOT	_	_
16	receive	_	VB	_	_	15	VC	_	_
17	$	_	$	_	_	20	NMOD	_	_
18	250	_	CD	_	_	17	AMOD	_	_
19	face	_	NN	_	_	20	NMOD	_	_
20	amount	_	NN	_	_	16	OBJ	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	Series	_	NNP	_	_	29	NMOD	_	_
23	A	_	NNP	_	_	29	NMOD	_	_
24	7.5	_	CD	_	_	25	AMOD	_	_
25	%	_	NN	_	_	29	NMOD	_	_
26	senior	_	JJ	_	_	29	NMOD	_	_
27	secured	_	VBN	_	_	29	NMOD	_	_
28	convertible	_	JJ	_	_	29	NMOD	_	_
29	notes	_	NNS	_	_	21	PMOD	_	_
30	due	_	JJ	_	_	29	APPO	_	_
31	Jan.	_	NNP	_	_	30	TMP	_	_
32	15	_	CD	_	_	31	NMOD	_	_
33	,	_	,	_	_	31	P	_	_
34	1995	_	CD	_	_	31	APPO	_	_
35	,	_	,	_	_	20	P	_	_
36	and	_	CC	_	_	20	COORD	_	_
37	200	_	CD	_	_	39	NMOD	_	_
38	common	_	JJ	_	_	39	NMOD	_	_
39	shares	_	NNS	_	_	36	CONJ	_	_
40	.	_	.	_	_	15	P	_	_

1	For	_	IN	_	_	11	ADV	_	_
2	each	_	DT	_	_	6	NMOD	_	_
3	$	_	$	_	_	6	NMOD	_	_
4	1,000	_	CD	_	_	3	AMOD	_	_
5	face	_	NN	_	_	6	NMOD	_	_
6	amount	_	NN	_	_	1	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	debentures	_	NNS	_	_	7	PMOD	_	_
9	,	_	,	_	_	11	P	_	_
10	holders	_	NNS	_	_	11	SBJ	_	_
11	received	_	VBD	_	_	0	ROOT	_	_
12	$	_	$	_	_	11	OBJ	_	_
13	250	_	CD	_	_	12	NMOD	_	_
14	of	_	IN	_	_	12	NMOD	_	_
15	Series	_	NNP	_	_	22	NMOD	_	_
16	B	_	NNP	_	_	22	NMOD	_	_
17	11	_	CD	_	_	18	AMOD	_	_
18	%	_	NN	_	_	22	NMOD	_	_
19	senior	_	JJ	_	_	22	NMOD	_	_
20	secured	_	VBN	_	_	22	NMOD	_	_
21	convertible	_	JJ	_	_	22	NMOD	_	_
22	notes	_	NNS	_	_	14	PMOD	_	_
23	due	_	JJ	_	_	22	APPO	_	_
24	Oct.	_	NNP	_	_	23	TMP	_	_
25	15	_	CD	_	_	24	NMOD	_	_
26	,	_	,	_	_	24	P	_	_
27	1998	_	CD	_	_	24	APPO	_	_
28	,	_	,	_	_	12	P	_	_
29	and	_	CC	_	_	12	COORD	_	_
30	200	_	CD	_	_	32	NMOD	_	_
31	common	_	JJ	_	_	32	NMOD	_	_
32	shares	_	NNS	_	_	29	CONJ	_	_
33	.	_	.	_	_	11	P	_	_

1	Bio-Technology	_	NNP	_	_	18	SBJ	_	_
2	,	_	,	_	_	1	P	_	_
3	a	_	DT	_	_	6	NMOD	_	_
4	New	_	NNP	_	_	6	NMOD	_	_
5	York	_	NNP	_	_	6	NMOD	_	_
6	maker	_	NN	_	_	1	APPO	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	genetically	_	RB	_	_	9	AMOD	_	_
9	engineered	_	VBN	_	_	10	NMOD	_	_
10	products	_	NNS	_	_	7	PMOD	_	_
11	for	_	IN	_	_	10	NMOD	_	_
12	human	_	NN	_	_	16	NMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	animal	_	NN	_	_	13	CONJ	_	_
15	health	_	NN	_	_	16	NMOD	_	_
16	care	_	NN	_	_	11	PMOD	_	_
17	,	_	,	_	_	1	P	_	_
18	said	_	VBD	_	_	0	ROOT	_	_
19	it	_	PRP	_	_	20	SBJ	_	_
20	made	_	VBD	_	_	18	OBJ	_	_
21	the	_	DT	_	_	23	NMOD	_	_
22	exchange	_	NN	_	_	23	NMOD	_	_
23	offer	_	NN	_	_	20	OBJ	_	_
24	to	_	TO	_	_	20	PRP	_	_
25	reduce	_	VB	_	_	24	IM	_	_
26	its	_	PRP$	_	_	28	NMOD	_	_
27	interest	_	NN	_	_	28	NMOD	_	_
28	payments	_	NNS	_	_	25	OBJ	_	_
29	.	_	.	_	_	18	P	_	_

